Related Experiment Video

Updated: Jan 20, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

Pediatric Monogenic Diabetes: A Unique Challenge and Opportunity

Anastasia Harris, Rochelle N Naylor

    Pediatric Annals
    |August 20, 2019
    PubMed

    Insights

    Monogenic diabetes, often misdiagnosed in children, includes congenital diabetes and MODY. Genetic testing is crucial for accurate diagnosis and targeted treatment, improving long-term health outcomes.

    Area of Science:

    • Pediatric Endocrinology
    • Clinical Genetics
    • Metabolic Disorders

    Background:

    • Monogenic diabetes affects ~120,000 in the US, frequently misdiagnosed.
    • 1-3% of pediatric diabetes cases are monogenic, including congenital diabetes and MODY.
    • Early diagnosis and targeted management significantly improve pediatric patient outcomes.

    Purpose of the Study:

    • To discuss challenges and opportunities in diagnosing and managing monogenic diabetes in children.
    • To highlight the importance of genetic testing for accurate diagnosis and treatment selection.
    • To differentiate monogenic diabetes from type 1 and type 2 diabetes in pediatric populations.

    Main Methods:

    • Review of current literature and diagnostic tools for monogenic diabetes.
    • Analysis of genetic testing's role in diagnosis and treatment.
    • Discussion of clinical management strategies for pediatric monogenic diabetes.

    Main Results:

    • Advancements enable better identification of patients with monogenic diabetes.
    • Genetic testing is essential for confirming diagnosis and guiding therapy.
    • Some patients may transition from insulin to sulfonylureas or discontinue therapy.

    Conclusions:

    • Accurate diagnosis of monogenic diabetes in children is critical.
    • Genetic testing and interpretation are necessary for effective management.
    • Addressing challenges in diagnosis and treatment can enhance quality of life for affected children.

    More Related Videos

    Guidelines for Elective Pediatric Fiberoptic Intubation11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    18.4K
    Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry03:37

    Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

    Published on: June 6, 2025

    391

    Related Concept Videos

    Other Unique Bacteria01:18

    Other Unique Bacteria

    Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic...
    423
    Second Uniqueness Theorem01:16

    Second Uniqueness Theorem

    Consider a region consisting of several individual conductors with a definite charge density in the region between these conductors. The second uniqueness theorem states that if the total charge on each conductor and the charge density in the in-between region are known, then the electric field can be uniquely determined.
    In contrast, consider that the electric field is non-unique and apply Gauss's law in divergence form in the region between the conductors and the integral form to the surface...
    2.6K
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
    3.2K
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    214
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    261
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    196